MRDVision
Tumor-informed whole-genome MRD assay using a baseline tumor/normal genome and serial blood-based ctDNA monitoring.
- Developer
- Inocras
- Intended use
- Mrd
- Cancer scope
- Hematologic neoplasms, Solid tumors
- Specimen
- FFPE tumor tissue, Peripheral whole blood
- Molecular modality
- DNA, DNA mutation
- Current version
- Current MRDVision configuration (2026-09)
- Evidence context
- 0 structured studies · 0 indexed performance results · 1 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.